1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : BIOTECH
  4. PRIME MEDICINE INC
Prime Medicine Inc XNAS: PRME
4.43 -0.25 (-5.34%)
2.3M
XNAS Volume

XNAS 23 Jan, 2026 4:30 PM (EST)

Watchlist

Portfolio

Alert

Prime Medicine Inc - PRME - stock price prediction, stock price target, analyst ratings from 11 analysts

Prime Medicine Inc has a share price target of US$ 6, revenue growth forecast of 76.5%, and profit growth estimate of -1.7% for FY25, based on top 11 analyst calls.